Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe

News Update


US Counties to Use Tech Firm's Software for COVID-19 Contact Tracing
News Update

Share on Stocktwits


Demand has been taking off for HealthSpace Data Systems' platform released two weeks ago.

In a news release, HealthSpace Data Systems Ltd. (HS:CSE; HSDLF:OTCMKTS) afforded three counties in different U.S. states access to its HSCloud Suite platform to begin the setup needed to trace COVID-19 contact within their borders.

This software-as-a-service firm in Canada provides efficiencies to state and local government agencies through its enterprise cloud and mobile platform that encompasses inspections, reporting, management and data.

HealthSpace Data will allow Bay County, Mich., Cass County, Ill., and Wilson County, N.C., to use the software free of charge until the COVID-19 crisis is over. Further, the state of Hawaii already completed internal trials with HSCloud Suite and is now using it for real-time tracing.

HealthSpace Data announced the release of HSCloud Suite two weeks ago. Since, it has been fielding numerous calls from interested parties and has been demonstrating the product online, several times a week.

"I am amazed at the demand we are already seeing," CEO Silas Garrison said in the release. "We are continually refining the process and configurations for each agency, as well as adding new product additions, so that our platform can continually be an exponential force multiplier to the work these agencies are doing."


1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of HealthSpace Data Systems Ltd., a company mentioned in this article.

Want to read more about Life Sciences Tools & Diagnostics and Healthcare Services investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe